IPOs

JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Xconomy
Tue, 01/8/19 - 09:19 am
IPOs
Alector
Alzheimer's disease
dementia
Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T
Endpoints
Sun, 01/6/19 - 01:58 pm
Poseida Therapeutics
IPOs
BCMA
CAR-T
The Week Ahead In Biotech: Conferences, Clinical Trials
Yahoo/Benzinga
Sun, 01/6/19 - 01:55 pm
JPMHC 2019
Axsome Therapeutics
Miragen Therapeutics
Aptorum Group
IPOs
Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments
Xconomy
Sat, 01/5/19 - 12:11 am
Poseida Therapeutics
CAR-T
IPOs
solid tumors
Pharma's 2019 Prognosis Hinges on These Key Themes
Bloomberg
Wed, 01/2/19 - 09:48 pm
drug pricing
Amarin
Vascepa
IPOs
cancer
TCR2 Shoots for $100 Million IPO in Early 2019
BioSpace
Wed, 01/2/19 - 11:41 am
TCR2 Therapeutics
IPOs
CAR-T
Did Moderna break the biotech IPO market?
Endpoints
Wed, 01/2/19 - 11:17 am
Moderna Therapeutics
IPOs
At the Eleventh Hour, Harpoon Therapeutics Signs up to Join the 2018 IPO Game
BioSpace
Fri, 12/28/18 - 01:11 pm
Harpoon Therapeutics
IPOs
tech
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
Fri, 12/28/18 - 12:57 pm
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
Gossamer Bio Plans to Raise $264.5 Million with IPO
BioSpace
Wed, 12/26/18 - 04:34 pm
Gossamer Bio
IPOs
3 trends in biotech to watch in 2019
Stat
Wed, 12/26/18 - 04:32 pm
biotech
IPOs
Money Keeps Flowing Into Life Science Funds – RiverVest Closes Oversubscribed 184.4 Million Fund
CP Wire
Tue, 12/18/18 - 10:02 am
RiverVest Venture Partners
IPOs
venture capital
Biofrontera cleared of wrongdoing in Nasdaq IPO
Fierce Biotech
Thu, 12/13/18 - 10:10 pm
Biofrontera
IPOs
NASDAQ
Four years after mega IPO, Circassia set for small-cap exchange
Fierce Biotech
Tue, 12/11/18 - 10:24 am
Circassia
IPOs
London
AIM
Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?
Endpoints
Mon, 12/10/18 - 09:58 am
IPOs
biotech
NASDAQ
Moderna, largest biotech to go public, fails to impress in market debut
Reuters
Sat, 12/8/18 - 12:29 pm
IPOs
biotech
Moderna Therapeutics
DiaMedica pulls off IPO to fund midphase stroke trial
Fierce Biotech
Fri, 12/7/18 - 10:44 am
IPOs
DiaMedica Therapeutics
chronic kidney disease
acute ischemic stroke
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever
Xconomy
Thu, 12/6/18 - 11:39 pm
IPOs
Moderna Therapeutics
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
Thu, 11/29/18 - 12:15 am
ViaCyte
stem cells
diabetes
IPOs
clinical trials

Pages